1. US and European Perspectives on Sinusoidal Obstruction Syndrome

3. Overview

4. Overview (cont)

5. Overview (cont)

6. Risk Assessment: CIBMTR VOD Risk Model

7. CIBMTR VOD Risk Model

8. Age and Risk of VOD/SOS

9. Conditioning Regimen and Risk of VOD/SOS

10. Observed VOD/SOS Among 4 Risk Groups

11. Preventing SOS

12. New EBMT Criteria for Diagnosing SOS/VOD in Adults

13. New EBMT Criteria for Diagnosing SOS/VOD in Adults (cont)

14. New EBMT Criteria for Severity Grading of Suspected SOS/VOD in Adults

15. EBMT Guidelines for Managing SOS/VOD

16. EBMT Guidelines for Managing SOS/VOD (cont)

17. Adverse Events Associated With Defibrotide in the International Compassionate Use Program

18. Other Measures for Treating SOS/VOD

19. Other Measures for Treating SOS/VOD (cont)

20. Summary

21. Abbreviations

22. Abbreviations (cont)